Trial Profile
A Prospective, Open-label, one-way, fixed sequence drug-drug interaction study evaluating the effect of Rifampin or Itraconazole on the pharmacokinetics of Itacitinib in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2019
Price :
$35
*
At a glance
- Drugs Itacitinib (Primary) ; Itraconazole; Rifampicin
- Indications Aplastic anaemia; Graft-versus-host disease; Hodgkin's disease; Malignant melanoma; Myelofibrosis; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Solid tumours; Ulcerative colitis
- Focus Pharmacokinetics
- 08 Jul 2019 Results published in the Journal of Clinical Pharmacology
- 28 Sep 2018 New trial record
- 01 Sep 2018 Preliminary results published in the Clinical Pharmacology in Drug Development Conference: 2018 Annual Meeting of the American College of Clinical Pharmacology